HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James L Januzzi Selected Research

Brain Natriuretic Peptide (Natrecor)

10/2022Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
1/2022Cardiac biomarkers retain prognostic significance in patients with heart failure and chronic obstructive pulmonary disease.
1/2022The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trial.
1/2022Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
1/2022Early B-Type Natriuretic Peptide Change in HFrEF Patients Treated With Sacubitril/Valsartan: A Pooled Analysis of EVALUATE-HF and PROVE-HF.
1/2022N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction.
1/2022Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
1/2022Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study.
1/2022Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study.
1/2022Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James L Januzzi Research Topics

Disease

267Heart Failure
10/2022 - 04/2004
46Myocardial Infarction
10/2022 - 05/2002
39Cardiovascular Diseases (Cardiovascular Disease)
09/2022 - 02/2008
33Acute Coronary Syndrome
01/2021 - 05/2002
30Dyspnea (Shortness of Breath)
01/2022 - 12/2004
23Inflammation (Inflammations)
10/2022 - 02/2008
19Fibrosis (Cirrhosis)
01/2022 - 03/2010
18Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 04/2004
15Chest Pain (Chest Pains)
11/2021 - 06/2004
13Atrial Fibrillation
01/2022 - 08/2006
13Left Ventricular Dysfunction
08/2020 - 07/2005
12Stroke (Strokes)
10/2022 - 08/2006
12Type 2 Diabetes Mellitus (MODY)
01/2022 - 08/2017
12Necrosis
01/2021 - 05/2002
11Cardiomyopathies (Cardiomyopathy)
05/2022 - 06/2008
11Ventricular Remodeling
01/2021 - 01/2013
10Heart Diseases (Heart Disease)
11/2020 - 10/2004
9Hypertension (High Blood Pressure)
01/2021 - 05/2010
8Diabetes Mellitus
01/2022 - 11/2007
8Hemorrhage
07/2018 - 05/2002
7Obesity
11/2021 - 04/2005
7Breast Neoplasms (Breast Cancer)
09/2021 - 05/2011
7Neoplasms (Cancer)
03/2021 - 09/2012
6Hypotension (Low Blood Pressure)
01/2022 - 04/2009
6Renal Insufficiency (Renal Failure)
01/2022 - 05/2002
6Chronic Renal Insufficiency
01/2022 - 05/2009
6Anemia
01/2022 - 06/2007
6Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
09/2016 - 08/2007
5Chronic Obstructive Pulmonary Disease (COPD)
10/2022 - 07/2006
5Overweight
01/2021 - 04/2005
5Cardiac Arrhythmias (Arrythmia)
01/2021 - 04/2015
5Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2021 - 05/2009
5Critical Illness (Critically Ill)
02/2016 - 08/2004
5Hypertrophy
04/2015 - 08/2013
5Coronary Disease (Coronary Heart Disease)
01/2010 - 09/2008
4Disease Progression
10/2022 - 03/2014
4Cardiac Sudden Death (Sudden Cardiac Arrest)
09/2022 - 06/2009
4COVID-19
07/2021 - 01/2020
4Peripheral Arterial Disease
01/2021 - 07/2018
4Myocardial Ischemia (Ischemic Heart Diseases)
10/2019 - 01/2005
4Ischemia
10/2019 - 05/2002
4Systolic Heart Failure
11/2018 - 10/2014
4Pathologic Constriction (Stenosis)
07/2018 - 11/2014
4Atherosclerosis
03/2016 - 07/2013
4Cardiotoxicity
09/2015 - 05/2011
4Cardiomegaly (Heart Hypertrophy)
04/2015 - 03/2010
4Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2012 - 04/2006
4Ischemic Stroke
09/2011 - 07/2009
3Kidney Diseases (Kidney Disease)
01/2022 - 01/2006

Drug/Important Bio-Agent (IBA)

164Biomarkers (Surrogate Marker)IBA
10/2022 - 05/2002
111Brain Natriuretic Peptide (Natrecor)FDA Link
10/2022 - 08/2004
110pro-brain natriuretic peptide (1-76)IBA
10/2022 - 12/2004
71Natriuretic PeptidesIBA
01/2022 - 06/2004
35Troponin T (Troponin T1)IBA
10/2022 - 12/2002
34TroponinIBA
11/2021 - 02/2006
18Troponin IIBA
01/2022 - 12/2002
16Galectin 3 (LGALS3)IBA
01/2021 - 09/2006
15C-Reactive ProteinIBA
10/2022 - 09/2008
15sacubitril and valsartan sodium hydrate drug combinationIBA
01/2022 - 01/2018
13empagliflozinIBA
01/2022 - 05/2017
11Trinitrotoluene (TNT)IBA
01/2022 - 05/2002
10omega-Chloroacetophenone (Mace)IBA
10/2022 - 12/2014
10CreatinineIBA
01/2022 - 05/2002
9Pharmaceutical PreparationsIBA
01/2022 - 01/2019
8Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2007
8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2017
8Cystatin CIBA
01/2022 - 02/2011
7Neprilysin (Neutral Endopeptidase)IBA
01/2021 - 08/2015
6SodiumIBA
01/2022 - 08/2017
6CanagliflozinIBA
01/2022 - 12/2019
6Mineralocorticoid Receptor AntagonistsIBA
01/2022 - 01/2015
6trans-crotonin (CTN)IBA
03/2021 - 12/2009
6Interleukin-33IBA
04/2015 - 07/2013
5insulin-like growth factor binding protein-related protein 1IBA
01/2022 - 11/2016
5Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 11/2017
5SymportersIBA
01/2022 - 08/2017
5Sodium-Glucose Transport ProteinsIBA
10/2021 - 05/2017
5Peptides (Polypeptides)IBA
01/2021 - 04/2011
5Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
01/2020 - 01/2006
5Glycoproteins (Glycoprotein)IBA
01/2020 - 05/2002
5Trastuzumab (Herceptin)FDA Link
01/2020 - 05/2011
5Endothelin-1 (Endothelin 1)IBA
11/2018 - 04/2011
5InterleukinsIBA
01/2018 - 08/2007
5Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
05/2010 - 08/2007
4AlbuminsIBA
10/2022 - 01/2005
4fibrin fragment D (D-dimer)IBA
07/2021 - 08/2006
4Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2021 - 01/2018
4Hemoglobins (Hemoglobin)IBA
01/2021 - 06/2007
4Growth Differentiation Factor 15IBA
05/2016 - 11/2014
4Tirofiban (Aggrastat)FDA Link
05/2005 - 05/2002
3Lipoprotein(a)IBA
11/2021 - 11/2020

Therapy/Procedure

89Therapeutics
03/2022 - 05/2002
13Catheters
01/2022 - 02/2006
6Length of Stay
01/2022 - 03/2007
6Percutaneous Coronary Intervention
01/2019 - 02/2006
6Patient Readmission
01/2019 - 01/2014
5Drug Therapy (Chemotherapy)
10/2022 - 05/2011
5Cardiac Resynchronization Therapy
08/2020 - 12/2014
4Mechanical Ventilators (Ventilator)
07/2021 - 09/2009
3Precision Medicine
10/2021 - 01/2016